MedTrace Logo

Patent Foramen Ovale in Children With Migraine Headaches

NCT00750594 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2017-12-26

No results posted yet for this study

Summary

This study will be the first to provide data about the relationship between PFO and migraine in children. By establishing the actual prevalence, we will better understand if PFO plays a role in the occurence of pediatric migraine and, thus, provide the incentive to perform additional studies evaluating whether PFO closure is an effective treatment option for pediatric migraine. For children with migraine headaches, discovering novel and effective treatments would be life altering.

Conditions

  • Migraine Headaches

Sponsors & Collaborators

Principal Investigators

  • Rachel McCandless, MD · University of Utah

  • LuAnn Minich, MD · University of Utah

  • James Bale, MD · University of Utah

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00750594 on ClinicalTrials.gov